Abstract
Myasthenia gravis crisis (MGC) is deifned as an exacerbation of myasthenia gravis (MG) weakness provoking an acute episode of respiratory failure that leads to institution of mechanical ventilation (MV). Weakness may involve respiratory muscles (altering respiratory mechanics) or bulbar muscles, which compromises airway protection and patency. MGC is the most dangerous complication of MG and is a life-threatening condition that requires immediate recognition and patient care in an intensive care unit setting for its optimal management (1).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Berrouschot J, Baumann I, Kalischewski P, Sterker M, Schneider D. Therapy of myasthenic crisis. Crit Care Med 1997; 25: 1228–1235.
Thomas CE, Mayer SA, Gungor Y, et al. Myasthenic crisis: clinical features, mortality, complications, and risk factors for prolonged intubation. Neurology 1997; 48: 1253–1260.
Mayer SA. Intensive care of the myasthenic patient. Neurology 1997; 48 (Suppl 5): S70–S75.
Bedlack RS, Sanders DB. How to handle myasthenic crisis. Postgrad Med 2000; 107: 211–214, 220–222.
Weijnen FG, Van Der Bilt A, Wokke JHJ, Wassenberg MWM, Oudenaarde I. Oral functions of patients with myasthenia gravis. Ann NY Acad Sci 1998; 841: 773–776.
Wittbrodt, ET. Drugs and myasthenia gravis. Arch Intern Med 1997; 157: 399–408.
Grob D. Natural history of myasthenia gravis. In: Engel AG, ed. Myasthenia Gravis and Myasthenic Disorders. New York, Oxford University Press, 1999, pp. 131–145.
Borodic G. Myasthenic crisis after botulinum toxin. Lancet 1998; 352: 1832.
Ropper AH. The Guillain-Barr ésyndrome. N Engl J Med 1992; 326: 1130–1136.
Putman MT, Wise RA. Myasthenia gravis and upper airway obstruction. Chest 1996; 109: 400–404.
Cridge PB, Allegra J, Gerhard H. Myasthenic crisis presenting as isolated vocal cord paralysis. Am J Emerg Med 2000; 18: 232–233.
DePippo KL, Holas MA, Reding MJ. Validation of the 3 oz water swallow test for aspiration after stroke. Arch Neurol 1992; 49: 1259–1261.
Suarez JI. Ventilatory management in the neurosciences critical care unit. In: Brazilian Academy of Neurology Minimonograph: Proceedings of the 19th Brazilian Congress of Neurology, 2000, Salvador, Brazil.
Suarez JI, Boonyapisit K, Zaidat OO, Kaminski HJ, Ruff RL. Predictors of mechanical ventilation in patients with myasthenia gravis exacerbation [abstract]. J Neurol Sci 2001; 187: S464.
Mayer SA, Thomas CE. Therapy of myasthenic crisis. Crit Care Med 1998; 26: 1136.
Maher J, Rutledge F, Remtulla H, et al. Neuromuscular disorders associated with failure to wean from the ventilator. Intensive Care Med 1995; 21: 737–743.
Vita G, Girlanda P, Puglisi RM, Marabello L, Messina C. Cardiovascular-reflex testing and single fiber eletromyography in botulism. Arch Neurol 1987;44:202– 206.
Suarez JI, Cohen ML, Larkins J, et al. Acute intermittent porphyria. Clinicopathologic correlation. Report of a case and review of the literature. Neurology 1997; 48: 1678–1683.
Anzueto A. Muscle dysfunction in the intensive care unit. Clin Chest Med 1999; 20: 435–452.
Bosch EP, Smith BE. Disorders of peripheral nerves. In: Bradley WG, Daroff RB, Fenichel GM, Marsden CD, eds. Neurology in Clinical Practice, 3rd ed., vol. 2. Boston, Butterworth-Heineman, 2000, pp. 2045–2130.
The acute respiratory distress syndrome network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342: 1301–1308.
Wijdicks FM. Management of airway and mechanical ventilation. In: Wijdicks FM, ed. The Clinical Practice of Critical Care Neurology. Philadelphia, Lippincott-Raven, 1997, pp. 25–45.
Borel CO, Teitelbaum JS, Hanley DF. Ventilatory drive and carbon dioxide response in ventilatory failure due to myasthenia gravis and Guillain-Barrésyndrome. Crit Care Med 1993; 21: 1717–1726.
Kokontis L, Gutmann L. Current treatment of neuromuscular diseases. Arch Neurol 2000; 57: 939–943.
Seybold ME. Treatment of myasthenia gravis. In: Engel AG, ed. Myasthenia Gravis and Myasthenic Disorders. New York, Oxford University Press, 1999, pp. 167–191.
Batocchi AP, Evoli A, Di Schino C, Tonali P. Therapeutic apheresis in myasthenia gravis. Ther Apher 2000; 4: 275–279.
Gajdos P, Chevret S, Clair B, Tranchant C, Chastang C. Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. Ann Neurol 1997;41:789–796.
Qureshi AI, Choudhry MA, Akbar MS, et al. Plasma exchange versus intravenous immunoglobulin treatment in myasthenic crisis. Neurology 1999; 52: 629–632.
Stricker RB, Kwiatkowska BJ, Habis JA, Kiprov DD. Myasthenic crisis. Response to plasmapheresis following failure of intravenous y-globulin. Arch Neurol 1993; 50: 837–840.
Drachman, DB. Myasthenia gravis. N Engl J Med 1994; 330: 1797–1810.
Dalakas, MC. Intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: present status and practical therapeutic guidelines. Muscle Nerve 1999; 22: 1479–1497.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Filho, J.A.M.F., Suarez, J.I. (2003). Neurocritical Care of Myasthenia Gravis Crisis. In: Kaminski, H.J. (eds) Myasthenia Gravis and Related Disorders. Current Clinical Neurology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-341-5_10
Download citation
DOI: https://doi.org/10.1007/978-1-59259-341-5_10
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4757-5942-6
Online ISBN: 978-1-59259-341-5
eBook Packages: Springer Book Archive